Shopping Cart
Remove All
Your shopping cart is currently empty
Ibritumomab tiuxetan
😃Good
Catalog No. T9901A-043Cas No. 206181-63-7
Alias IDEC-129, IDEC129, BAY86-5128, BAY865128
Ibritumomab tiuxetan (IDEC-129) is an antibody targeting CD20, conjugated to a radioactive isotope via a chelating agent Tiuxetan, and can be used in radioimmunotherapy.
Ibritumomab tiuxetan
Ibritumomab tiuxetan
😃Good
Catalog No. T9901A-043Alias IDEC-129, IDEC129, BAY86-5128, BAY865128Cas No. 206181-63-7
Ibritumomab tiuxetan (IDEC-129) is an antibody targeting CD20, conjugated to a radioactive isotope via a chelating agent Tiuxetan, and can be used in radioimmunotherapy.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | Inquiry | Inquiry | |
| 5 mg | $483 | Inquiry | Inquiry | |
| 10 mg | $692 | Inquiry | Inquiry | |
| 25 mg | $1,080 | Inquiry | Inquiry | |
| 50 mg | $1,490 | Inquiry | Inquiry | |
| 100 mg | $1,970 | Inquiry | Inquiry |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.66% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Ibritumomab tiuxetan (IDEC-129) is an antibody targeting CD20, conjugated to a radioactive isotope via a chelating agent Tiuxetan, and can be used in radioimmunotherapy. |
| In vitro | Ibritumomab tiuxetan is an anti-CD-20 mouse monoclonal antibody linked to the radioisotope 90-yttrium (90Y) by the chelating agent tiuxetan. [1] |
| Synonyms | IDEC-129, IDEC129, BAY86-5128, BAY865128 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD20 Protein (VLP) at 16 μg/mL can bind Ibritumomab. The EC50 is 0.01364 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Tiuxetan |
| Gene ID | |
| Uniprot ID | |
| Target | CD20 |
| Molecular Weight | 148 kDa |
| Cas No. | 206181-63-7 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa-Tiuxetan |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Ibritumomab tiuxetan | purchase Ibritumomab tiuxetan | Ibritumomab tiuxetan cost | order Ibritumomab tiuxetan | Ibritumomab tiuxetan in vitro | Ibritumomab tiuxetan molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.